Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation - 02/04/21
Doi : 10.1016/j.jinf.2020.11.006
Yan Yan a, b, 1, Xiufeng Jiang c, 1, Juanjuan Fu d, 1, Jiehui Huang c, Yuanwang Qiu a, e, Difei Ding b, Lina Ge b, Hao Zhang e, Lihua Huang a, e, ⁎ 
, Xiaojie Lu c, f, ⁎ , Qinxue Hu g, h, ⁎
, Xiaojie Lu c, f, ⁎ , Qinxue Hu g, h, ⁎ a The International Joint Research Laboratory for Infection and Immunity (China-Germany), The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
b Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
c Department of Respiratory and Critical Care Medicine, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
d Department of Pathology, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
e Department of Infectious Disease, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
f Department of Neurosurgery, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, China
g State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China
h Institute for Infection and Immunity, St. George's, University of London, London, United Kingdom
⁎Corresponding authors.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Key words : SARS-CoV-2, COVID-19, Lung transplantation (LT), Immune response, Residual virus
Le texte complet de cet article est disponible en PDF.
© 2020
Publié par Elsevier Masson SAS.
Vol 82 - N° 4
P. 84-123 - avril 2021 Retour au numéro
Article précédent
- Co-occurrence of mcr-9, extended spectrum ?-lactamase (ESBL) and AmpC genes in a conjugative IncHI2A plasmid from a multidrug-resistant clinical isolate of Salmonella diarizonae
- Yuanlong Pan, Yuan Fang, Xiaofeng Song, Na Lyu, Luping Chen, Yuqing Feng, Xuebin Xu, Baoli Zhu, Yongfei Hu
- The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust
- Thomas Gardiner, Graham Cooke, Sarah Fidler, Nichola Cooper, Louise Young
Bienvenue sur EM-consulte, la référence des professionnels de santé.